AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, UK, with major R&D sites in Gothenburg, Gaithersburg, Boston, Shanghai, and Beijing. The company researches, develops, and commercializes innovative medicines across oncology, respiratory, rare diseases, and other therapeutic areas. Its current R&D pipeline includes 197 projects, supported by 16 established blockbuster medicines.
For robotics engineers, the relevant work sits at the intersection of automation, data science, AI, and next-generation therapeutics such as cell therapies and precision medicine. Engineering challenges in this context typically involve automating laboratory workflows, developing robotic platforms for high-throughput screening, and integrating AI-driven control systems with physical instrumentation in regulated pharmaceutical environments. These systems must meet stringent validation and reproducibility requirements dictated by GMP and regulatory compliance.
AstraZeneca operates across multiple technical domains including data science and AI, which interface directly with robotics and automation infrastructure. The company's scale - spanning six major global research hubs and nearly 200 pipeline projects - creates demand for robust, scalable automation solutions that can operate reliably across diverse laboratory and manufacturing contexts.
